Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · IEX Real-Time Price · USD
+1.63 (8.18%)
Jun 2, 2023, 4:00 PM EDT - Market closed

Total Valuation

ELVN has a market cap or net worth of $886.02 million. The enterprise value is $593.87 million.

Market Cap 886.02M
Enterprise Value 593.87M

Important Dates

The next estimated earnings date is Wednesday, August 2, 2023, before market open.

Earnings Date Aug 2, 2023
Ex-Dividend Date n/a

Share Statistics

ELVN has 41.11 million shares outstanding. The number of shares has increased by 543.59% in one year.

Shares Outstanding 41.11M
Shares Change (YoY) +543.59%
Shares Change (QoQ) +177.58%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

The trailing PE ratio is 13.14.

PE Ratio 13.14
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.04
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 423.28
EV / Sales n/a
EV / EBITDA 278.42
EV / EBIT 398.30
EV / FCF n/a

Financial Position

The company has a current ratio of 27.24

Current Ratio 27.24
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is 1.10% and return on invested capital (ROIC) is 14.60%.

Return on Equity (ROE) 1.10%
Return on Assets (ROA) 1.10%
Return on Capital (ROIC) 14.60%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, ELVN has paid $88,000 in taxes.

Income Tax 88,000
Effective Tax Rate 5.90%

Stock Price Statistics

The stock price has increased by +374.29% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +374.29%
50-Day Moving Average 20.26
200-Day Moving Average 16.65
Average Volume (30 Days) 132,869

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.03M
Pretax Income 1.49M
Net Income 1.40M
EBIT 1.49M
Earnings Per Share (EPS) $1.64
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 292.16M
Total Debt n/a
Net Cash 292.16M
Net Cash Per Share $7.11
Equity / Book Value 291.42M
Book Value Per Share 7.09
Working Capital 287.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.25 million and capital expenditures -$259,000, giving a free cash flow of -$39.51 million.

Operating Cash Flow -39.25M
Capital Expenditures -259,000
Free Cash Flow -39.51M
FCF Per Share -$2.13
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield 0.16%
FCF Yield -4.46%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -543.59%
Shareholder Yield -543.59%
Dividend Details

Analyst Forecast

The average price target for ELVN is $27.00, which is 25.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $27.00
Price Target Difference 25.29%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a